BRN Discussion Ongoing

[Fact Finder]

It’s National Road Safety week .

Pedestrian deaths have more than doubled on Victorian roads this year .

It’s not just children , 30-39 year olds make up the second biggest group injured on our roads.

Distraction has been a major factor in several deaths , music on , looking at phone the main offenders.

Let’s get the magic IP into cars asap & help save life’s .

Loving the slow & steady build this week , hopefully uncle Sean can bless us with a big juicy Telco Ann soon .

What about an AKIDA based phone App that says "Fool you are about to walk in front of a moving vehicle." FF

 

[Dhm]

My wife who I love dearly, (or should that be nearly) asked how my new investment is going as she correctly stated the NASDAQ has been routed over the last month. I showed her the following two charts and she disdainfully commented, ‘about time you got something right!’

To quote Dr Smith, “Oh the pain, the pain.”

 

[cosors]

View attachment 6892

New branding on display, this looks fab, go chippers !!

Does the stag mean anything?

 

[MrNick]

Does the stag mean anything?
View attachment 6952

Might be a prop for one-shot learning.

 

[MrNick]

I think there’s a cow just next to it?

 

[buena suerte :-)]

Does the stag mean anything?
View attachment 6952

Not sure ... but it's nice to see 'Ken' is involved and not forgotten .... Go Kenny

 

[Gies]

My wife who I love dearly, (or should that be nearly) asked how my new investment is going as she correctly stated the NASDAQ has been routed over the last month. I showed her the following two charts and she disdainfully commented, ‘about time you got something right!’

To quote Dr Smith, “Oh the pain, the pain.”

View attachment 6949 View attachment 6950

Sounds familiar

 

[EastFreo]

Hi All
My first attempt at posting so hope it works. Saw this on TECHRADAR today.
Perhaps it may be using our chip. Much lower power and better resolution.
EF

 

[Tothemoon24]

What about an AKIDA based phone App that says "Fool you are about to walk in front of a moving vehicle." FF

Does the stag mean anything?
View attachment 6952

 

[Perhaps]

What about an AKIDA based phone App that says "Fool you are about to walk in front of a moving vehicle." FF

Maybe less smartphones would be the easiest solution to help people crossing streets.

 

[Bravo]

Does the stag mean anything?
View attachment 6952

It's most likely a model used to demonstrate one-shot learning. The orange blob beside it is probably a tiger. That's my best guess.

 

[TECH]

It's most likely a model used to demonstrate one-shot learning. The orange blob beside it is probably a tiger. That's my best guess.

You're 100% correct....though it's the MOOSE that Anil used in one of the demo's months ago...just saying

 

[Tothemoon24]

You're 100% correct....though it's the MOOSE that Anil used in one of the demo's months ago...just saying

Might be time to change the Moose too the GOLDEN GOOSE

 

[ItsKane]

Does the stag mean anything?
View attachment 6952

John Deere

 

[Baisyet]

To reminisce. The conversations that raged for a week over that crinkled tablecloth!

I was in stitches over some of it!

Seems so long ago… and look how far they’ve come now!

Immaculately pressed and Hollywood lights.

Forwards and conquer!

and look who are beside them

 

[hamilton66]

I think it must be very hard work now for the WANCA's to find a solid foundation for down ramping Brainchip.

Clearly companies of varying size are marketing real world products containing the AKIDA technology solution and a credibility giant of the industrial world in the form of Mercedes Benz has validated the AKIDA technology advantage and pronounced Brainchip the artificial intelligence experts.

On top of which no other than ARM has publicly partnered with Brainchip to provide joint ARM AKIDA solutions through their joint engineering partners Edge Impulse and Always Ai.

All that is left for these commentators is a 20th century flawed model for calculating the value of a new technology company in the form of a price to earnings ratio. I personally doubt that some of the commentators actually understand the maths that underpin the ratio let alone understand when it is an appropriate measure of value for a technology company.

I know that it is a different science altogether but let us walk these commentators down the road and around the corner to a biotechnology company seeking to find a cure for disabling or fatal medical conditions.

If we did this probably what we would find is company like more than 95% of those companies engaged in cutting edge medical research that is trying to produce a cure for a medical condition and funding its work completely from debt and tax rebates and incentives.

Notwithstanding this at the time they produce scientific proof of concept large pharmaceutical companies from around the globe will line up with cheque books and offer billions of dollars based upon the length of the remaining exclusion period and the addressable market value.

At the time this happens most of these research institutions even if they are on the larger end will have racked up losses year on year sometimes running into the hundreds of millions of dollars and issued large numbers of shares into the billions if they are listed on the ASX and never turned one single cent in income let alone made a profit.

Once such companies however have proof in hand every sophisticated investment advisory company around the globe such as Roth Capital Partners will be able to produce a valuation despite the complete absence of there ever having been earnings.

In fact Roth Capital Partners and others like them because they have persons on staff with appropriate academic qualifications and experience of the biopharmaceutical research industry will most likely have commenced coverage earlier than point of cure and been providing valuations for perhaps a couple of years based upon future milestones being achieved. Not a single penny of income anywhere to be found yet they can produce such valuations based on the exclusion of competition period and size of the addressable market.

There are three types of stupidity involved with those who do not attribute a company like Brainchip with a value well in excess of its present market capitalisation:

1. The first type comes from the absence of sufficient intelligence to know that someone or something could in fact develop a technology advance that is capable of creating a new paradigm and that the 20th century method for valuing such a technology has no application as we are in the 21st Century where technology is the new currency in every single industry that exists or can be imagined.

2. The second type of stupidity is one which is based upon personal ego which blinds an otherwise intelligent person from seeing anything which contradicts prior learning. Sometimes this form of stupidity is embraced because of laziness.

3. There is also a third type of stupidity and that is the kind which is based on a failure of confidence through the acquired experience of having failed while trying to compete fairly on the ASX and so they have resorted to 'white collar crime' to eek out success through manipulation of less sophisticated retail investors. This is a very sad form of success but none the less one which many seem prepared to accept.

The 1,000 Eyes led by the likes of @Diogenese retired engineer and @uiux relentless researcher have as a massive self learning unit created a wall of knowledge that allows those who embrace the need to do their own research to remain properly informed about Brainchip and its technology and market place achievements and through this we have all acquired the intellectual strength to ignore the stupidity that would otherwise hold sway.

My opinion only DYOR
FF

AKIDA BALLISTA

​

Great post F/F. There's a 4th type of stupidity - bloody laziness. Don't be so arrogant to comment on a company that u clearly don't understand, without doing a serious deep dive, getting ur head around the potential, current contracts, market moat, competitors in the space, patents - I could keep going. To judge BRN on earnings vs market cap alone is sheer bloody laziness. Experts, that have no expertise, dictated to by computer programmes, upon which they make judgements. It's a lot easier than actually doing some hard work, and taking some responsibility /ownership of ur opinion.
GLTA

 

[cassip]

Does the stag mean anything?

You're 100% correct....though it's the MOOSE that Anil used in one of the demo's months ago...just saying

So it refers to the so called Mercedes moose test (elk-test)? Quote from Wikipedia:
"A moose test (vehicle dynamics test) is a driving maneuver that simulates swerving to avoid an obstacle that suddenly appears on the road. The test is used to check the driving stability of passenger cars. At speeds between about 50 km/h and 80 km/h, a lane change to the left is performed without braking and, after a short straight stretch, a lane change to the right is performed. The vehicle should neither swerve nor tip over sideways.

The term "moose test" was coined by the press at the end of 1997 after a Mercedes-Benz A-Class overturned during a test by journalists in Sweden. "

Translated with www.DeepL.com/Translator (free version)

 

[Baisyet]

I think it must be very hard work now for the WANCA's to find a solid foundation for down ramping Brainchip.

Clearly companies of varying size are marketing real world products containing the AKIDA technology solution and a credibility giant of the industrial world in the form of Mercedes Benz has validated the AKIDA technology advantage and pronounced Brainchip the artificial intelligence experts.

On top of which no other than ARM has publicly partnered with Brainchip to provide joint ARM AKIDA solutions through their joint engineering partners Edge Impulse and Always Ai.

All that is left for these commentators is a 20th century flawed model for calculating the value of a new technology company in the form of a price to earnings ratio. I personally doubt that some of the commentators actually understand the maths that underpin the ratio let alone understand when it is an appropriate measure of value for a technology company.

I know that it is a different science altogether but let us walk these commentators down the road and around the corner to a biotechnology company seeking to find a cure for disabling or fatal medical conditions.

If we did this probably what we would find is company like more than 95% of those companies engaged in cutting edge medical research that is trying to produce a cure for a medical condition and funding its work completely from debt and tax rebates and incentives.

Notwithstanding this at the time they produce scientific proof of concept large pharmaceutical companies from around the globe will line up with cheque books and offer billions of dollars based upon the length of the remaining exclusion period and the addressable market value.

At the time this happens most of these research institutions even if they are on the larger end will have racked up losses year on year sometimes running into the hundreds of millions of dollars and issued large numbers of shares into the billions if they are listed on the ASX and never turned one single cent in income let alone made a profit.

Once such companies however have proof in hand every sophisticated investment advisory company around the globe such as Roth Capital Partners will be able to produce a valuation despite the complete absence of there ever having been earnings.

In fact Roth Capital Partners and others like them because they have persons on staff with appropriate academic qualifications and experience of the biopharmaceutical research industry will most likely have commenced coverage earlier than point of cure and been providing valuations for perhaps a couple of years based upon future milestones being achieved. Not a single penny of income anywhere to be found yet they can produce such valuations based on the exclusion of competition period and size of the addressable market.

There are three types of stupidity involved with those who do not attribute a company like Brainchip with a value well in excess of its present market capitalisation:

1. The first type comes from the absence of sufficient intelligence to know that someone or something could in fact develop a technology advance that is capable of creating a new paradigm and that the 20th century method for valuing such a technology has no application as we are in the 21st Century where technology is the new currency in every single industry that exists or can be imagined.

2. The second type of stupidity is one which is based upon personal ego which blinds an otherwise intelligent person from seeing anything which contradicts prior learning. Sometimes this form of stupidity is embraced because of laziness.

3. There is also a third type of stupidity and that is the kind which is based on a failure of confidence through the acquired experience of having failed while trying to compete fairly on the ASX and so they have resorted to 'white collar crime' to eek out success through manipulation of less sophisticated retail investors. This is a very sad form of success but none the less one which many seem prepared to accept.

The 1,000 Eyes led by the likes of @Diogenese retired engineer and @uiux relentless researcher have as a massive self learning unit created a wall of knowledge that allows those who embrace the need to do their own research to remain properly informed about Brainchip and its technology and market place achievements and through this we have all acquired the intellectual strength to ignore the stupidity that would otherwise hold sway.

My opinion only DYOR
FF

AKIDA BALLISTA

​

Cant agree More FF, I own couple of those biotech Companies shares and i know what you mean exactly. I sold one of them and i still own another one. How SP plays with those bio tech amazing and here we are with BRN its boggles my mind. Cheers

 

[Slade]

I think most of us are going to freak out (in a good way) when we begin to understand more about Brainchip and ARM's technology partnership.

Remebering that SiFive is also a technology partner and this is what Jerome said about them: “We are pleased to partner with SiFive and have the opportunity to have our Akida technology integrated with their market-leading product offerings, creating an efficient combination for edge compute,”

 

[Straw]

Great post F/F. There's a 4th type of stupidity - bloody laziness. Don't be so arrogant to comment on a company that u clearly don't understand, without doing a serious deep dive, getting ur head around the potential, current contracts, market moat, competitors in the space, patents - I could keep going. To judge BRN on earnings vs market cap alone is sheer bloody laziness. Experts, that have no expertise, dictated to by computer programmes, upon which they make judgements. It's a lot easier than actually doing some hard work, and taking some responsibility /ownership of ur opinion.
GLTA

I feel it would be reasonable to assume certain parties are being deliberately obtuse to suit an agenda of maintaining sufficient volatility.